Taxane pathway.
作者信息
Oshiro Connie, Marsh Sharon, McLeod Howard, Carrillo Michelle Whirl, Klein Teri, Altman Russ
机构信息
Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre, Montreal, Quebec, Canada.
出版信息
Pharmacogenet Genomics. 2009 Dec;19(12):979-83. doi: 10.1097/FPC.0b013e3283335277.
Abstract
摘要
相似文献
1
Taxane pathway.紫杉烷途径
Pharmacogenet Genomics. 2009 Dec;19(12):979-83. doi: 10.1097/FPC.0b013e3283335277.
2
The taxoids: paclitaxel and docetaxel.紫杉烷类药物：紫杉醇和多西他赛。
Lancet. 1994 Nov 5;344(8932):1267-72. doi: 10.1016/s0140-6736(94)90754-4.
3
Docetaxel in the management of ovarian cancer.多西他赛在卵巢癌治疗中的应用
Expert Rev Anticancer Ther. 2005 Apr;5(2):203-14. doi: 10.1586/14737140.5.2.203.
4
Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.基于多西他赛化疗的改善潜力：药理学综述。
Br J Cancer. 2005 Jul 25;93(2):173-7. doi: 10.1038/sj.bjc.6602698.
5
Determination of fraction unbound docetaxel using microequilibrium dialysis.
Anal Biochem. 2004 Aug 1;331(1):192-4. doi: 10.1016/j.ab.2004.03.045.
6
Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.拓展视野：多西他赛在非小细胞肺癌、卵巢癌和乳腺癌中应用的最新进展
Semin Oncol. 2002 Jun;29(3 Suppl 12):1-3. doi: 10.1053/sonc.2002.34253.
7
Taxoids.紫杉烷类
Eur J Cancer. 1995;31A(5):824-6. doi: 10.1016/0959-8049(95)00104-q.
8
Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer.卡巴他赛，一种用于激素难治性转移性前列腺癌男性患者的紫杉烷类药物。
Oncology (Williston Park). 2010 Oct;24(10 Suppl):46-8.
9
Docetaxel: a review of its use in metastatic breast cancer.多西他赛：其在转移性乳腺癌治疗中的应用综述
Drugs. 2005;65(17):2513-31. doi: 10.2165/00003495-200565170-00007.
10
[Docetaxel and novel strategies in the treatment of NSCLC].[多西他赛与非小细胞肺癌治疗的新策略]
Tumori. 2005 Nov-Dec;91(6):suppl 11-22.
引用本文的文献
1
Inducing breast cancer cell death: The impact of taxodone on proliferation through apoptosis.诱导乳腺癌细胞死亡：紫杉醇对通过凋亡实现增殖的影响。
Heliyon. 2024 Jul 4;10(13):e34044. doi: 10.1016/j.heliyon.2024.e34044. eCollection 2024 Jul 15.
2
Prediction models of persistent taxane-induced peripheral neuropathy among breast cancer survivors using whole-exome sequencing.利用全外显子组测序预测乳腺癌幸存者中紫杉烷诱导的持续性周围神经病变的模型
NPJ Precis Oncol. 2024 May 16;8(1):102. doi: 10.1038/s41698-024-00594-x.
3
circRNAs in drug resistance of breast cancer.环状 RNA 在乳腺癌耐药中的作用。
Oncol Res. 2023 Jan 31;30(4):157-172. doi: 10.32604/or.2022.027547. eCollection 2022.
4
Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: Part 2-functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer.利用大型合作组试验得出的 GWAS 数据评估乳腺癌患者接受紫杉烷类药物引起的周围神经病变（TIPN）的风险：第 2 部分-与乳腺癌患者 TIPN 风险相关的 SNP 簇的功能意义。
Support Care Cancer. 2023 Feb 21;31(3):178. doi: 10.1007/s00520-023-07617-6.
5
Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting.靶向线粒体和氧化应激治疗癌症及化疗引起的肌肉减少症。
Antioxid Redox Signal. 2023 Feb;38(4-6):352-370. doi: 10.1089/ars.2022.0149. Epub 2022 Dec 29.
6
Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.紫杉醇类药物所致乳腺癌神经毒性的遗传药理学：系统评价和荟萃分析。
Clin Transl Sci. 2022 Oct;15(10):2403-2436. doi: 10.1111/cts.13370. Epub 2022 Aug 17.
7
Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark.单核苷酸多态性与基于紫杉烷的化疗在绝经前乳腺癌中的疗效：丹麦基于人群的队列研究。
Breast Cancer Res Treat. 2022 Jul;194(2):353-363. doi: 10.1007/s10549-022-06596-2. Epub 2022 Apr 30.
8
Chemometric and Transcriptomic Profiling, Microtubule Disruption and Cell Death Induction by Secalonic Acid in Tumor Cells.色烯酸在肿瘤细胞中通过化学计量学和转录组学分析、微管破坏和细胞死亡诱导作用。
Molecules. 2020 Jul 15;25(14):3224. doi: 10.3390/molecules25143224.
9
Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.有机阴离子转运多肽：癌症药理学中的新兴作用。
Mol Pharmacol. 2019 May;95(5):490-506. doi: 10.1124/mol.118.114314. Epub 2019 Feb 19.
10
The impact of pharmacokinetic gene profiles across human cancers.人类癌症中药物代谢动力学基因谱的影响。
BMC Cancer. 2018 May 21;18(1):577. doi: 10.1186/s12885-018-4345-2.
本文引用的文献
1
Chromosomal instability determines taxane response.染色体不稳定性决定紫杉烷反应。
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8671-6. doi: 10.1073/pnas.0811835106. Epub 2009 May 19.
2
The roles of beta-tubulin mutations and isotype expression in acquired drug resistance.β-微管蛋白突变和亚型表达在获得性耐药中的作用。
Cancer Inform. 2007 Apr 27;3:159-81.
3
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.影响接受紫杉烷类和铂类化合物治疗的上皮性卵巢癌患者临床结局的基因多态性：一项基于韩国人群的研究。
Gynecol Oncol. 2009 May;113(2):264-9. doi: 10.1016/j.ygyno.2009.01.002. Epub 2009 Feb 8.
4
Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer.紫杉醇治疗卵巢癌的药物遗传学研究。
Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):130-7. doi: 10.1111/j.1742-7843.2008.00351.x. Epub 2008 Dec 16.
5
Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor.核受体介导的抗癌药物对细胞色素P450 3A4的诱导作用：孕烷X受体的关键作用。
Cancer Chemother Pharmacol. 2009 Jun;64(1):35-43. doi: 10.1007/s00280-008-0842-3. Epub 2008 Oct 7.
6
Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients.ABCB1基因多态性2677G>T/A和3435C>T与转移性乳腺癌患者紫杉醇单药治疗临床结局的相关性
Ann Oncol. 2009 Feb;20(2):272-7. doi: 10.1093/annonc/mdn624. Epub 2008 Oct 3.
7
Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel.溶剂型紫杉醇与纳米白蛋白结合型紫杉醇的随机交叉药代动力学研究
Clin Cancer Res. 2008 Jul 1;14(13):4200-5. doi: 10.1158/1078-0432.CCR-07-4592.
8
Pharmacogenetic pathway analysis of docetaxel elimination.多西他赛消除的药物遗传通路分析
Clin Pharmacol Ther. 2009 Feb;85(2):155-63. doi: 10.1038/clpt.2008.95. Epub 2008 May 28.
9
Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel.CYP1B1*3 等位基因与接受多西他赛治疗的前列腺癌患者生存情况的关联。
Mol Cancer Ther. 2008 Jan;7(1):19-26. doi: 10.1158/1535-7163.MCT-07-0557. Epub 2008 Jan 9.
10
Taxanes, microtubules and chemoresistant breast cancer.紫杉烷类、微管与化疗耐药性乳腺癌
Biochim Biophys Acta. 2008 Apr;1785(2):96-132. doi: 10.1016/j.bbcan.2007.10.004. Epub 2007 Nov 12.
Zotero 插件